Average Co-Inventor Count = 7.34
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Forma Therapeutics, Inc. (22 from 124 patents)
2. Array Biopharma Inc. (10 from 328 patents)
3. Genentech, Inc. (9 from 3,198 patents)
4. Valo Health, Inc. (7 from 29 patents)
5. Forma Tm, LLC (7 from 10 patents)
6. Valo Early Discovery, Inc. (5 from 15 patents)
7. Other (2 from 831,952 patents)
8. Vertex Pharmaceuticals, Inc. (1 from 1,141 patents)
54 patents:
1. 12336981 - Compounds and compositions for the inhibition of NAMPT
2. 12049466 - Fused bicyclic compounds useful as ubiquitin-specific peptidase 30 inhibitors
3. 12043623 - Purinones as ubiquitin-specific protease 1 inhibitors
4. 12018030 - Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
5. 11795171 - Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
6. 11739071 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
7. 11547701 - Compounds and compositions for the inhibition of NAMPT
8. 11479564 - Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT)
9. 11279687 - Compounds and compositions for the inhibition of NAMPT
10. 11247987 - Inhibiting ubiquitin specific peptidase 30
11. 11174273 - Quinazoline analogs as receptor tyrosine kinase inhibitors
12. 11161848 - Purinones as ubiquitin-specific protease 1 inhibitors
13. 10981915 - Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
14. 10934299 - Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
15. 10927130 - Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors